In study after study, the psychoactive drug ketamine has given profound and fast relief to many people suffering from severe depression. But these studies have a critical shortcoming: Participants usually can tell whether ...
Oct 19, 2023
2
40
A saline injection treatment widely used for calcific tendinopathy—a common, painful condition caused by a build-up of calcium in the rotator cuff tendons of the shoulder—provides no meaningful benefit over placebo, concludes ...
Oct 11, 2023
0
18
Treatment-resistant depression (TRD) is a particularly challenging form of major depressive disorder. As Albino Oliveira-Maia, head of the Champalimaud Foundation's Neuropsychiatry Unit and the study's national coordinator ...
Oct 4, 2023
0
77
Lab data in cells has shown that siRNA has the potential to treat COVID-19 infection better than existing antivirals, according to new research from UNSW's Kirby and RNA Institutes, published today in Antiviral Research.
Aug 10, 2023
0
2
Scientists at St. Jude Children's Research Hospital created a hepatoblastoma (liver cancer) model that more accurately reflects the pathology and genomics of the disease. Research using the model pointed toward potential ...
Jul 7, 2023
0
11
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a fatal motor neuron disease that causes people to gradually lose control of their muscles. There is no cure, and current treatments focus on reducing ...
Jun 1, 2023
0
116
Scientists at the University of East Anglia are a step closer to creating a new generation of light-activated cancer treatments. The futuristic-sounding treatment would work by switching on LED lights embedded close to a ...
Feb 16, 2023
0
72
Even as they've revolutionized cancer treatment, drugs known as immune checkpoint inhibitors can produce a range of adverse, immune-related side effects. In a new study, scientists at Dana-Farber Cancer Institute identify, ...
Dec 16, 2022
0
104
Ketamine, an established anesthetic and increasingly popular antidepressant, dramatically reorganizes activity in the brain, as if a switch had been flipped on its active circuits, according to a new study by Penn Medicine ...
Dec 1, 2022
1
888
A vaccine (DCVax-L), trialed at King's College Hospital and other centers around the world, using patients' immune cells to target brain cancer can extend survival by many months or, in some cases, years, the final unblinded ...
Nov 21, 2022
0
82
